scholarly journals Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up

Hepatology ◽  
2012 ◽  
Vol 56 (2) ◽  
pp. 516-522 ◽  
Author(s):  
Umid M. Sharapov ◽  
Lisa R. Bulkow ◽  
Susan E. Negus ◽  
Philip R. Spradling ◽  
Chriss Homan ◽  
...  
Keyword(s):  
Young Children ◽  
Hepatitis A ◽  
Maternal Antibody ◽  
Infants And Young Children

Immunogenicity of an Inactivated Hepatitis A Vaccine in Infants and Young Children

2007 ◽  
Vol 26 (2) ◽  
pp. 116-122 ◽  
Author(s):  
Beth P. Bell ◽  
Susan Negus ◽  
Anthony E. Fiore ◽  
Julia Plotnik ◽  
Kathy Boaz Dhotre ◽  
...  
Keyword(s):  
Young Children ◽  
Hepatitis A ◽  
Infants And Young Children

scholarly journals Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial

2016 ◽  
Vol 63 (8) ◽  
pp. 1113-1121 ◽  
Author(s):  
Linda Barlow-Mosha ◽  
Konstantia Angelidou ◽  
Jane Lindsey ◽  
Moherndran Archary ◽  
Mark Cotton ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Young Children ◽  
Randomized Trial ◽  
Long Term Follow Up ◽  
Infants And Young Children

Melamine-Related Urinary Stones in 195 Infants and Young Children: Clinical Features within 2 Years of Follow-Up

2011 ◽  
Vol 87 (4) ◽  
pp. 429-433 ◽  
Author(s):  
Jian Guo Wen ◽  
Qing Long Chang ◽  
An Feng Lou ◽  
Zhen Zhen Li ◽  
Shan Lu ◽  
...  
Keyword(s):  
Young Children ◽  
Clinical Features ◽  
Urinary Stones ◽  
Infants And Young Children

scholarly journals Persistence of seropositivity among persons vaccinated for hepatitis A during infancy by maternal antibody status: 15-year follow-up

Hepatology ◽  
2016 ◽  
Vol 63 (3) ◽  
pp. 703-711 ◽  
Author(s):  
Philip R. Spradling ◽  
Lisa R. Bulkow ◽  
Susan E. Negus ◽  
Chriss Homan ◽  
Michael G. Bruce ◽  
...  
Keyword(s):  
Hepatitis A ◽  
Maternal Antibody

Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)

Vaccine ◽  
2003 ◽  
Vol 21 (31) ◽  
pp. 4588-4592 ◽  
Author(s):  
V. Usonis ◽  
V. Bakasénas ◽  
R. Valentelis ◽  
G. Katiliene ◽  
D. Vidzeniene ◽  
...  
Keyword(s):  
Young Children ◽  
Hepatitis A ◽  
Booster Vaccination ◽  
Antibody Titres ◽  
Infants And Young Children

scholarly journals Incidence of atrial septal defects in children attended the Cardiac Center of Ethiopia during January 2016 to December 2018

2020 ◽  
Author(s):  
Abdu Hassen Musa ◽  
Mekbeb Afework ◽  
Mohammed Bedru ◽  
Shibikom Tamirat ◽  
Keyword(s):  
Young Children ◽  
Addis Ababa ◽  
Age Groups ◽  
Surgical Closure ◽  
Septal Defects ◽  
Large Size ◽  
Echocardiographic Findings ◽  
Cardiac Center ◽  
Infants And Young Children

AbstractBackgroundAlthough it appears that an atrial septal defect (ASD) occurs frequently in Ethiopia there are only a few published studies available so far on this matter. This study is therefore aimed to evaluate the prevalence and echocardiographic characteristics of ASDs in children (aged ≤ 15 years) attended a cardiac referral center in Ethiopia.MethodsThis retrospective study reviewed the sociodemographic data and the initial echocardiographic findings of the children with ASDs who were diagnosed at the Cardiac Center of Ethiopia (CCE), Addis Ababa, from January 2016 to December 2018.ResultsA total of 116 children (56.9% females and 43.1% males) with a mean age of 3.47± 3.72 years (range: 15 days to 15 years) were diagnosed with ASDs. The most prevalent age groups were infancy (50%) and early childhood (29.3%). All the studied cases were diagnosed with ostium secundum ASD while there were no cases with ostium primum, sinus venosus and coronary sinus defects. The most frequent ostium secundum ASD was large size (61.2%) and was more frequent in infants (23.3%) and young children (21.6% of all cases).ConclusionOstium secundum ASD is the most prevalent IAS defect and more common among female cases. Large size ostium secundum ASD is more frequent in the studied children and is more prevalent in infants and young children. This survey may provide data for the currently lacking statistics on ASDs at the CCE and might be helpful for the management and follow-up of children with ASDs. Scheduled follow-up and intervention studies are required to evaluate the incidence and patterns of spontaneous and surgical closure of ASD and their outcomes.

scholarly journals Neoadjuvant chemotherapy for brain tumors in infants and young children

2015 ◽  
Vol 15 (5) ◽  
pp. 488-492 ◽  
Author(s):  
Junya Iwama ◽  
Hideki Ogiwara ◽  
Chikako Kiyotani ◽  
Keita Terashima ◽  
Kentaro Matsuoka ◽  
...  
Keyword(s):  
Neoadjuvant Chemotherapy ◽  
Young Children ◽  
Brain Tumors ◽  
Tumor Resection ◽  
Tumor Diameter ◽  
Second Look ◽  
Initial Surgery ◽  
The Mean ◽  
Infants And Young Children

OBJECT Because of their large size and high vascularity, complete removal of brain tumors in infants and young children is often difficult. In most cases the degree of resection is associated with prognosis. Neoadjuvant chemotherapy may facilitate resection by reducing the vascularity of the tumor. The authors evaluated the effectiveness of neoadjuvant chemotherapy in the management of these tumors. METHODS The authors performed a retrospective review of infants and young children who underwent tumor removal after neoadjuvant chemotherapy. RESULTS Nine consecutive patients underwent resection after neoadjuvant chemotherapy during the period February 2004 to December 2012. The mean age at diagnosis was 18 months (range 2–50 months). The average largest tumor diameter was 71 mm (range 30–130 mm) at initial surgery. Five patients underwent partial resection, and 4 underwent biopsy as the initial surgery. The histopathological diagnoses were ependymoma in 2 patients, anaplastic ependymoma in 1, primitive neuroectodermal tumor (PNET) in 2, choroid plexus carcinoma in 1, atypical teratoid/rhabdoid tumor (AT/RT) in 1, glioblastoma in 1, and embryonal tumor with abundant neuropil and true rosettes in 1. After 2–4 courses of multiagent chemotherapy (mainly with vincristine, cyclophosphamide, etoposide, and cisplatin), the second-look surgery was performed. In 1 patient with a PNET, intratumoral hemorrhage was observed after 2 courses of chemotherapy. The mean interval between the initial and the second-look surgery was 3 months. The tumor volume was reduced to varying degrees in 5 patients (56%) after chemotherapy. Intraoperatively, the vascularity of the tumor was considerably reduced, and the tumor was more circumscribed in all cases. Gross-total resection was achieved in 8 patients (89%) and neartotal resection in 1 (11%). Histopathological examination demonstrated fibrotic tissue circumscribing the tumor in 6 of 9 cases (67%). The average blood loss was 20% of the estimated blood volume, and 3 patients (33%) required a blood transfusion. There was no surgical mortality. One patient had transient dysphasia postoperatively. The mean follow-up period was 28 months. At the last follow-up, 2 patients (22%) had died (1 died of tumor progression and 1 of sepsis), and 4 patients (44%) had no tumor recurrence. CONCLUSIONS Neoadjuvant chemotherapy for brain tumors in infants and young children was effective in reduction of tumor vascularity and clarification of the tumor-brain interface, which significantly facilitated maximal tumor resection.

Sign in / Sign up

Export Citation Format

Share Document